Paxil CR and Avandamet were taken off the market.

  No. Paxil CR and Avandamet have NOT been taken off the market. There is some confusion however because on March 4th, U.S. marshals seized stocks of Paxil CR and Avandamet from several manufacturing sites of GlaxoSmith Kline. This has caused a widespread shortage of both Paxil CR and Avandamet.

  The problem was that manufacturing problems resulted in flawed tablets and unreliable amounts of pharmaceutical ingredients.

  There was concern that the Paxil CR tablets could split apart. This could potentially result in patients getting a portion of a tablet that may lack active ingredient or not have the controlled-release effect.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote